Stocks

The interim results for Ramelius Resources Limited (ASX:RMS) were released last week, making it a good time to revisit its performance. Ramelius Resources reported in line with analyst predictions, delivering revenues of AU$305m and statutory earnings per share of AU$0.015, suggesting the business is …

PSC Insurance Group (ASX:PSI) First Half 2023 Results Key Financial Results Revenue: AU$138.5m (up 17% from 1H 2022). Net income: AU$21.3m (up 31% from 1H 2022). Profit margin: 15% (up from 14% in 1H 2022). EPS: AU$0.061 (up from AU$0.05 in 1H 2022). earnings-and-revenue-history …

Carlton Investments Limited (ASX:CIN) is about to trade ex-dividend in the next four days. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books …

Galena Mining (ASX:G1A) First Half 2023 Results Key Financial Results Net loss: AU$4.27m (loss widened by 106% from 1H 2022). AU$0.01 loss per share (further deteriorated from AU$0.005 loss in 1H 2022). earnings-and-revenue-history All figures shown in the chart above are for the trailing …

Mount Gibson Iron (ASX:MGX) First Half 2023 Results Key Financial Results Revenue: AU$152.0m (up 456% from 1H 2022). Net income: AU$7.40m (up from AU$65.6m loss in 1H 2022). Profit margin: 4.9% (up from net loss in 1H 2022). The move to profitability was driven …

Cedar Woods Properties (ASX:CWP) First Half 2023 Results Key Financial Results Revenue: AU$152.3m (down 13% from 1H 2022). Net income: AU$9.06m (down 36% from 1H 2022). Profit margin: 6.0% (down from 8.1% in 1H 2022). The decrease in margin was driven by lower revenue. …

Redx Pharma and Jounce Therapeutics Inc (NASDAQ: JNCE) agreed to merge via a proposed all-share transaction. Redx is a clinical-stage biotechnology company focused on discovering and developing small molecule, targeted therapeutics for cancer and fibrotic diseases and cancer-associated fibrosis. The combined group's highest priority …